Menu ×


Autotransfusion Devices Market Analysis by Application (Orthopedic Surgery, Cardiovascular Surgery, Neurological Surgery, Gynecological Surgery, Obstetrics, and Others); by Product Type (Autotransfusion Systems, and Accessories); and by End User (Hospitals, Specialty Clinics, and Others) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2033

  • Text Size:

Inflation And Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

Request Insights

Purchasing power in the couPurchasing power in the country is expected to fell nearly by 2.5%. On the other hand, European countries to see the worst coming in the form of energy crisis especially in upcoming winters!! Right after COVID-19, inflation has started gripping the economies across the globe. Higher than anticipated inflation, especially in western world had raised concerns for national banks and financial institutions to control the economic loss and safeguard the interest of the businesses. Increased interest rates, strong USD inflated oil prices, looming prices for gas and energy resources due to Ukraine-Russia conflict, China economic slowdown (~4% in 2022) disrupting the production and global supply chain and other factors would impact each industry negatively.                                                         Request Insights

Read More


  • ProCell Surgical Inc. announce their first patient blood management device, ProCell.  Procell’s Sponge Blood Recovery the extraction of blood during surgical process in the intraoperative transfusion.
  • Haemnotics Corporation join hands with Epic, a leading company for delivering electronic health record system, to provide innovative medical solutions and better results for patients.

Global Autotransfusion Devices Market Highlights Over 2023 - 2033

Base Year


Forecast Year




Base Year Market Size (2022)

~USD 250 Million

Forecast Year Market Size (2033)

~USD 400 Million

The global autotransfusion devices market is estimated to garner a revenue of nearly ~USD 250 million by the end of 2033 by growing at a CAGR of ~6% over the forecast period, i.e., 2023 – 2033. Further, the market generated a revenue of around ~USD 400 million in the year 2022. Fueling number of patients in need of surgical care. As per the WHO, over 2 million surgical procedures were performed in 2018. Moreover, the instances of surgical burden is to rise by approximately 30% in next few years.

Autotransfusion-Devices-Market-ScopeGet more information on this report: Request Sample PDF

Rising need of blood donation and increase volumes of donated blood, with the rising need of blood transfusion is to boost the growth of global autotransfusion devices market. Globally, every year about 118.5 million units of donated blood is collected. Additionally, in India, nearly 25-30 thousand people are in need of liver transplants and about 50,000 person gets heart attack. Furthermore, around 6,721 people are waiting for organ transplantation in the United Kingdoms.

Global Autotransfusion Devices Market: Growth Drivers and Challenges

Growth Drivers

  • Growing Burden of Chronic Disease on the World

According to the records of National Library of Medicine, worldwide every 3 in 5 deaths is caused by cardiovascular disease, cancer, chronic lung problem and diabetes.

  • Rising Number of Surgical Procedures Operated Across the World

Globally nearly 11% of worldwide disease requires surgical treatment. Furthermore, there are nearly 310 million surgical procedures are carried out every year.

  • Increase in Number of People with Kidney Problems

Nearly 850 million people all over the world have developed some sort of kidney disease.

  • Surge in Population of Old-Adult

According to the WHO, by 2030, every 1 in 6 people is likely to be aged 60 years or above. Moreover, between 2015-2050, the worldwide older population is to get double from nearly 12% to 22%.

  • Rising Need for Blood Transfusion

According to the World Health Organization, the global share of blood transfusion in children is 54% and nearly 76% on the adults above 60 years of age.


  • Higher Prevalence of Minimally Invasive Surgery
  • Increased Usage of Hemostatic Devices for the Transfusions
  • Difficulty in Separating Contaminants from Blood

Minimal invasion is highly adopted, factors such as, less pain, fast recovery, minimal blood loss, and higher comfort of patients is resulting higher number of people choosing it over traditional surgery. Therefore, it is likely to hamper the market growth.

The autotransfusion devices market is segmented and analyzed for demand and supply by application into orthopedic surgery, cardiovascular surgery, neurological surgery, gynecological surgery, obstetrics, and others. Out of all, the cardiovascular surgery segment is anticipated to hold the largest market size by the end of 2033. Increased instances of cardiovascular issues are creating higher demands for transplantation, surgery and autotransfusion and is likely to drive the growth of the segment. According to the World Health Organization, nearly 17.9 million people are dying of cardiovascular disease every year and cardiovascular is the primary reason for most of the deaths in the world.

Major Macro-Economic Indicators Impacting the Market Growth


According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Autotransfusion Devices Market Regional Synopsis

Regionally, the global autotransfusion devices market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in North America is projected to hold the largest market share by the end of 2033. This growth is expected on the account of higher cases of chronic disease among the population is to propel the market growth in the United States. According to the Centers for Disease Control and Prevention, every 6 in 10 adults are living a chronic disease and every 4 in 10 have more than 1 chronic problem. Furthermore, rise in organ transplantation and other surgeries. In the United States, at the current time, nearly 121,000 people are waiting for kidney transplantation.


The global autotrabsfusion devices market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

Market Segmentation

Our in-depth analysis of the global autotransfusion devices market includes the following segments:

By Application

  • Orthopedic Surgery
  • Cardiovascular Surgery
  • Neurological Surgery
  • Gynecological Surgery
  • Obstetrics
  • Others

By Product Type

  • Autotransfusion Systems
  • Accessories

By End User

  • Hospitals
  •  Specialty Clinics
  • Others

Top Featured Companies Dominating the Global Autotransfusion Devices Market

  • ProCell Surgical Inc.
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • BD (Becton, Dickinson and Company)
  • Fresenius SE & Co. KGaA
  • Medtronic
  • Beijing Jingjing Medical Equipment Co., Ltd.
  • Haematonics Corporation
  • LivaNova PLC
  • Zimmer Biomet
  • Gen World Medical Devices



Related Reports

Disclaimer | Privacy Policy | Terms & Conditions | LOB

Copyright © 2022 Research Nester. All Rights Reserved